- Home
- KOD vs FORR Comparison
KOD vs FORR Comparison
Compare KOD & FORR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOD
- FORR
- Stock Information
- Founded
- KOD 2009
- FORR 1983
- Country
- KOD United States
- FORR United States
- Employees
- KOD N/A
- FORR N/A
- Industry
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- FORR Diversified Commercial Services
- Sector
- KOD Health Care
- FORR Consumer Discretionary
- Exchange
- KOD Nasdaq
- FORR Nasdaq
- Market Cap
- KOD 188.9M
- FORR 193.5M
- IPO Year
- KOD 2018
- FORR 1996
- Fundamental
- Price
- KOD $3.62
- FORR $9.57
- Analyst Decision
- KOD Hold
- FORR
- Analyst Count
- KOD 3
- FORR 0
- Target Price
- KOD $9.00
- FORR N/A
- AVG Volume (30 Days)
- KOD 294.1K
- FORR 63.5K
- Earning Date
- KOD 08-13-2025
- FORR 07-29-2025
- Dividend Yield
- KOD N/A
- FORR N/A
- EPS Growth
- KOD N/A
- FORR N/A
- EPS
- KOD N/A
- FORR N/A
- Revenue
- KOD N/A
- FORR $422,269,000.00
- Revenue This Year
- KOD N/A
- FORR N/A
- Revenue Next Year
- KOD N/A
- FORR $2.04
- P/E Ratio
- KOD N/A
- FORR N/A
- Revenue Growth
- KOD N/A
- FORR N/A
- 52 Week Low
- KOD $1.92
- FORR $8.50
- 52 Week High
- KOD $11.60
- FORR $20.62
- Technical
- Relative Strength Index (RSI)
- KOD 46.82
- FORR 42.40
- Support Level
- KOD $3.52
- FORR $9.59
- Resistance Level
- KOD $3.78
- FORR $10.11
- Average True Range (ATR)
- KOD 0.35
- FORR 0.52
- MACD
- KOD -0.05
- FORR -0.12
- Stochastic Oscillator
- KOD 30.77
- FORR 15.38
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
About FORR Forrester Research Inc.
Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.